A full-length human KCNG4 cDNA clone was purchased from Source bioscience (IRCMp5012B0629D) and cloned in-house into a pcDNA3 based expression plasmid (CMV-genex-polioIRESmCherry) both with or without a C-terminal HA tag. The p.Val419Met mutation was introduced by site-directed mutagenesis (Stratagene) according to the manufacturer’s protocols and sequences of the plasmids were confirmed by Sanger Sequencing. The clone expressing KV2.1 alongside a nuclear GFP reporter in the pCAGGS-IRES2-nucEGFP vector has been described previously (Saitsu et al., 2015 (link)) and was a kind gift from Prof. Hiromoto Saitsu.
Antibodies used were anti-HA mouse monoclonal (12B12, #MMS-101P, Biolegend), anti-Na+/K+ ATPase rabbit monoclonal (ab76020, Abcam), anti-mCherry rat monoclonal (M11217), anti-β-actin mouse monoclonal (a2228, Sigma), anti-KV2.1 rabbit polyclonal (APC-012, Alomone), anti-KV6.4 mouse monoclonal (N458/10, NeuroMab), anti-KV2.1 mouse monoclonal (K89/34, ab192761, Abcam), and anti-HA rabbit monoclonal (C29F4 #3724, Cell Signaling).
Free full text: Click here